Table I.
Values of integrated density [intden (A.U.)], indicative of fluorescence intensity, of the different cell times and treatments of ESWT-treated and control non-ESWT-treated equine CB-MSCs.
| Cell line/Treatment | MitoTrack control | MitoTrack ESWT | H2DCFDA control | H2DCFDA ESWT |
|---|---|---|---|---|
| 1801/TR1 | 622.92 ± 194.63 | 743.47 ± 193.65 | 336.45 ± 107.57 | 385.73 ± 132.44 |
| 1803/TR1 | 722.03 ± 211.21 | 788.54 ± 243.57 | 226.34 ± 95.75 | 228.330 ± 88.13 |
| 1810/TR1 | 635.77 ± 189.14 | 687.04 ± 169.34 | 264.33 ± 90.14 | 243.70 ± 79.41 |
| 1801/TR2 | 3108.47 ± 5928.58 | 812.65 ± 232.21 | 3373.75 ± 6224.95 | 895.98 ± 288.19 |
| 1803/TR2 | 976.83 ± 297.77 | 827.39 ± 274.91 | 987.15 ± 351.06 | 725.08 ± 315.52 |
| 1810/TR2 | 798.26 ± 234.20 | 723.98 ± 193.49 | 790.29 ± 266.24 | 702.48 ± 225.52 |
| 1801/TR3 | 644.32 ± 167.12 | 606.20 ± 151.43 | 737.90 ± 241.83 | 608.37 ± 201.69 |
| 1803/TR3 | 922.55 ± 329.22 | 783.48 ± 235.36 | 930.95 ± 407.30 | 658.88 ± 300 |
| 1810/TR3 | 593.77 ± 182.30 | 605.06 ± 170.78 | 549.93 ± 199.35 | 547.77 ± 217.84 |
Data presented as mean ± SD.
MitoTrack — Stain for mitochondrial membrane potential (MMP); H2DCFDA — Stain for reactive oxygen species (ROS); ESWT — Extracorporeal shock wave therapy; AU — Arbitrary units.